Entries by Rebecca Mercer

Updated CanREValue Interim Data Report now available!

As part of a broader engagement strategy, the CanREValue Collaboration has launched a stakeholder consultation process. In late 2019, the CanREValue Collaboration undertook public stakeholder consultation regarding the Interim Data Report developed by the CanREValue Data Working Group. From this consultation, we received 20 constructive submissions from a diverse set (more…)

New Publication: Real-world comparative effectiveness of 2nd line ipilimumab for metastatic melanoma…

ARCC and the CanREValue Collaboration are excited to share our recent study, using Ontario based real-world data to generate real-world evidence on the comparative effectiveness of 2nd line ipilimumab. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada  Dai WF,  Beca JM, Croxford (more…)

OICR Recruiting: Biostatistician, Diagnostic Development

Position: Biostatistician Site: MaRS Centre, Toronto Department: Diagnostic Development Reports To: Director, Diagnostic Development Salary: Commensurate with level of experience Hours: 35 hours/week Status: Full-time, Temporary (Two years, with potential for renewal) The Ontario Institute for Cancer Research (OICR) is seeking a talented Biostatistician to join the Diagnostic Development (DD) program, which is (more…)

Cancellation of the 2020 ARCC Conference

Every year, we look forward to connecting with the ARCC Network in person at our annual conference. But, given the growing concerns around COVID-19,  we have made the difficult decision to cancel our in-person conference, scheduled to be held in Saskatoon from May 25th-26th, 2020. We are very disappointed, the (more…)